tbuckley/cabot-search huggingface dataset:
Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry
Authors: Gabriel Brisou, Guillaume Cartron, Emmanuel Bachy, Catherine Thieblemont, Cristina Castilla-Llorente, Fabien Le Bras, François-Xavier Gros, Michael Loschi, Roch Houot, Remy Dulery, Fabrice Jardin, Magalie Joris, Choquet Sylvain, Franck Morschhauser, Stephanie Guidez, Olivier Hermine, Laurianne Drieu La Rochelle, Sylvain Carras, Blandine Guffroy, Pierre Bories, Rene-Olivier Casasnovas, Julie Abraham, Steven Le Gouill, Pascale Cony-Makhoul, Elodie Gat, Benoit Tessoulin
Journal: Blood (2023)
Pooled Exposure-Response (ER) and Quantitative Benefit/Risk (B/R) Analyses Support the Approved Copanlisib Intermittent Dosing Regimen
Authors: Peter N Morcos, Jonathan Moss, Charles Phelps, Florian JR Hiemeyer, Barrett H. Childs, Martin Dreyling, Pier Luigi Zinzani, Dirk Garmann
Journal: Blood (2023)
Pharmacokinetics and Immunogenicity of Abbv-383, a B-Cell Maturation Antigen (BCMA) × CD3 Bispecific T-Cell-Redirecting Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Akshanth R Polepally, Carla Biesdorf, Muhammad Erfan Uddin, Nils Boehm, Jeremy A Ross, Shaji Kunnathu Kumar, Peter M. Voorhees, Anita D'Souza, Katja Weisel, Orlando Bueno, Chetasi Talati, Rajeev M Menon
Journal: Blood (2023)
Efficacy Evaluation of a Tetracyclic Triterpene Compound Targeting Multiple Apoptosis Proteins for the Development of a Multiple Myeloma Treatment
Authors: Hye Ran Kim, Young Eun Lee, Ha Jin Lim, Yong Jun Choi, Joo Heon Park, Jong Hee Shin, Chang Soo Park, Myung Geun Shin
Journal: Blood (2023)
Setting Industry Standards for Patient Engagement, Partnership, Allyship and Care: The Patient Vision Project
Authors: Biree Andemariam, Tamara Schryver, Rae Blaylark, Ralph Colasanti, Nirmish Shah, Charles R. Jonassaint, Rucha Shah, Cassandra Trimnell, Teonna Woolford, Janie Davis, Eva Gallagher, Ahmar U Zaidi, Holly John, Sujit Sheth
Journal: Blood (2023)
Digital PCR Assay for Evaluation of CD19-CAR-T Cells In Vivo Expansion in Aggressive B-Cell Lymphoma: Impact on Clinical Outcome
Authors: Laura Ventura, Alicia Serrano, Blanca Ferrer Lores, Rafael Hernani, Alexandru Robert Vasile Tudorache, Ana Isabel Teruel, Ana Saus Carreres, Alfonso Ortiz Algarra, Ignacio Arroyo Martin, Juan Carlos Hernandez Boluda, Jose Luis Pinana Sanchez, Ariadna Perez, Ana Benzaquen, Carlos Solano, Maria Jose Terol Castera
Journal: Blood (2023)
Acquired Mutations in Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study
Authors: Jennifer R. Brown, Jessica Li, Barbara F. Eichhorst, Nicole Lamanna, Susan M. O'Brien, Constantine S. Tam, Luqui Qiu, Vanitha Ramakrishnan, Ruiqi Huang, Yang Shi, Adam Idoine, Tommi Salmi, Aileen Cleary Cohen, Mazyar Shadman
Journal: Blood (2023)
LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses
Authors: Yu Yan, Kanwaldeep Singh, Emily Hartung, Brendan Lee, Pradhariny Prabagaran, Dina Khalaf, Alejandro Garcia-Horton, Brian Leber, Irwin Walker, Kylie L. Lepic, Maria Kleppe, Hugh Young Young Rienhoff Jr., Jonathan Bramson, Tobias Berg
Journal: Blood (2023)
Use of Cilta-Cel CAR T Cells Following Previous Use of a BCMA-Directed CAR T-Cell Product in Heavily Treated Patients with Relapsed/Refractory Multiple Myeloma: A Single Institution Case Series
Authors: Narsis Attar, Diana Cirstea, Andrew R. Branagan, Andrew J. Yee, Matthew J. Frigault, Noopur Raje
Journal: Blood (2023)
Longitudinal Safety of Luspatercept in the Treatment of Anemia in Patients with Myelofibrosis: Results from the ACE-536-MF-001 Study
Authors: Rami S. Komrokji, Aaron T. Gerds, Claire N Harrison, Jean-Jacques Kiladjian, Ruben Mesa, Prithviraj Bose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Francesco Passamonti
Journal: Blood (2023)
Reducing Operating Room (OR) Cancellations: Results from a Quality Improvement Study from a Tertiary Care Children's Cancer Center
Authors: Mohammed Sahabi, Viqaruddin Mohammed, Seham Alqahtani, Amani Al-Kofide, Ahmed AlAsseri, Mohammed Zulfiqar, Hawazen Alsaedi, Ibrahim Ghemlas, Mouhab F. Ayas, Sarah Ramiz, Rania AlObairi, Daina Bushnak, Neameh Farhan, Adel Alhmouz, Khaldoun Alshorman, Alya Shuaib, Waad Almutairi, Tarek M Owaidah, Mahasen Alsaleh
Journal: Blood (2023)
Health-Related Quality of Life (HRQL) in Cutaneous T-Cell Lymphoma: Psychological Burden and Influencing Factors from Mycosis Fungoides and Sézary Syndrome Patients in China
Authors: Tun-Ying Hsu, Huiping Sun, Zhiming Li, Wenrong Huang, Linna Xie, Xiaojing Yan, Haifeng Zhao, Ki Hyon Kim, Yuankai Shi
Journal: Blood (2023)
Oral Decitabine/Cedazuridine Is a Tolerable and Effective Ambulatory Regimen for Patients with Advanced Myeloproliferative Neoplasms
Authors: Ganesh Sivakumar, Shivani Handa, Andrew Srisuwananukorn, Douglas Tremblay, John Mascarenhas, Marina Kremyanskaya, Yelena Ginzburg, Xiaoli Wang, Ronald Hoffman
Journal: Blood (2023)
Demographic Characteristics and Treatment Patterns in Veterans with Multiple Myeloma: A Comprehensive Analysis from the Veterans Affairs Database (2000-2020)
Authors: Gurbakhash Kaur, Aishwarya Sannareddy, Aaron Perkins, Hui Yang, Somtochukwu Egbuonu, Adeel Khan, Aimaz Afrough, Ankit Kansagra, Larry D. Anderson, Carlos Alvarez
Journal: Blood (2023)
Machine Learning Models Predict Molecular Genetic Subtypes of Multiple Myeloma from Whole-Slide Bone Marrow Aspirate Smears
Authors: Joshua E Lewis, Conrad W Shebelut, Michel Attieh, Michael C Horwath, Anurag Khanna, Omar M Al-Rusan, Tanya Ponnatt, Geoffrey H Smith, David A Gutman, Vikas A Gupta, Ahmed Aljudi, Lee A.D. Cooper, David L Jaye
Journal: Blood (2023)
Easix Indices Predict CRS and Overall Survival in Adult CAR-T Cell Recipients
Authors: Eleni Gavriilaki, Ifigeneia Tzannou, Anna Vardi, Ioannis Tsonis, Maria Liga, Konstantinos Girkas, Maria Ximeri, Zoi Bousiou, Maria Bouzani, Eleutheria Sagiadinou, Panagiotis Dolgyras, Vasiliki Bampali, Despina Mallouri, Tatiana Tzenou, Ioannis Batsis, Nikolaos Spyridis, Damianos Sotiropoulos, Achilles Anagnostopoulos, Dimitrios Karakasis, Eleni Papadaki, Panagiotis Tsirigotis, Alexandros Spyridonidis, Maria Angelopoulou, Ioanna Sakellari, Ioannis Baltadakis
Journal: Blood (2023)
Symptoms, Functioning, and Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Talquetamab: Updated Patient-Reported Outcomes from the Phase 1/2 MonumenTAL-1 Study
Authors: Carolina Schinke, Cyrille Touzeau, Albert Oriol, María-Victoria Mateos, Don A. Stevens, Leo Rasche, Xiang Qin, Kelly Kato, Timothy Ming, Eva G Katz, Katharine S Gries, Michela Campagna, Tara J Masterson, Brandi W Hilder, Jaszianne Tolbert, Thomas Renaud, Christoph Heuck, Philippe Moreau, Jesús San-Miguel, Paula Rodríguez Otero, Ajai Chari
Journal: Blood (2023)
Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification
Authors: Hsin-Yu Lu, Wan Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hsin-An Hou, Hwei-Fang Tien, Wen-Chien Chou
Journal: Blood (2023)
Nationwide Trends in Hospitalizations with Heart Failure Preserved Ejection Fraction and Subsequent Cardiovascular Outcomes in Elderly Patients with Leukemia [2016-2019]
Authors: Zainab Muslehuddin, Fazal Khan, Vaishnavi Arote, Mariam Ashfaque, Mahboob Younus Shaik, Shilpa Reddy, Meena Kumari Bellamkonda, Hafeezuddin Ahmed, Farah Al Haj, Rupak Desai
Journal: Blood (2023)
Fludarabine Lymphodepletion Exposure Is Associated with Idecabtagene Vicleucel Toxicity in Relapsed and Refractory Multiple Myeloma Patients: Real-World Experience from the US Myeloma Immunotherapy Consortium
Authors: Charlotte B Wagner, Karen Sweiss, Eric Anto, Rebecca Gonzalez, Omar Alexis Castaneda Puglianini, Ciara Louise L. Freeman, Filip Ionescu, Krina K. Patel, Christopher Ferreri, Mahmoud Gaballa, Leyla Shune, Joseph P McGuirk, Surbhi Sidana, Vanna Hovanky, Jack Khouri, Danai Dima, Hamza Hashmi, James A Davis, Aimaz Afrough, Gurbakhash Kaur, Larry D. Anderson, Peter A. Forsberg, Megan Herr, Doris K. Hansen, Douglas Sborov, Mehmet H. Kocoglu
Journal: Blood (2023)
Symptom Burden in Idiopathic Multicentric Castleman Disease: Protocol for the Development of a Novel Standardized Patient Reported Outcome Measure
Authors: Sudipto Mukherjee, Philip A Powell, Jill Carlton, Clara Murukia, Antonio Adolfo Guerra Soares Brandão, Karthik Ramasamy, Frankie Shupo, Grace Wayi-Wayi, Karan Kanhai, Kelley C Dacus, Kelly Makarounas-Kirchmann, Anju Devianee Keetharuth
Journal: Blood (2023)
Influence of Activated Protein C Resistance on Short-Term Hospital Outcomes Following Admission for Acute Ischemic Stroke in the United States
Authors: Salini Ajitha, Saisree Reddy Adla Jala, Suma Sri Chennapragada, Mehndi Dandwani, Saloni Savani, Vaishnavi Singh, Arcita Hanjani Pramudita, Shruti Aggarwal, Fnu Aisha, Shaheen Sombans, Prince Kwabla Pekyi-Boateng, Shriya Goyal, Sindhu Thevuthasan, Yogeshwaree Ramphul, Hemamalini Sakthivel, Kamleshun Ramphul, Shivani Sharma
Journal: Blood (2023)
Impact of Diabetes Mellitus in Hospital Outcomes Among Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A NIS 2016 to 2020 Database Study
Authors: Niraj Neupane, Arnav Srivastava, Amir Mahmoud, Pravash Budhathoki, Anish Shah, Shubham Agrawal, Utsav Joshi, Himal Kharel, Aditya Sanjeevi, Binod Dhakal
Journal: Blood (2023)
Association of Autoimmune Diseases and Their Effect on Outcomes of Heparin-Induced Thrombocytopenia: An Analysis of the National Inpatient Sample (2016-2020)
Authors: Arnav Srivastava, Tripti Jain, Amir Mahmoud, Himal Kharel, Abdullah Orakzai, Basant Eltaher, Shobhit Piplani
Journal: Blood (2023)
Single-Center Experience of Decitabine/Venetoclax in Newly Diagnosed Older AML Patients with Non-Favorable Genetics: Bridging to Allo-HCT or Treatment Continuation
Authors: David Alber, Christoph Rummelt, Tim Strüßmann, Andrés Rettig, Valeria Shlyakhto, Paul La Rosée, Martin Henkes, Elizaveta Bubnova, Tobias Ma, Johanna Thomas, Gabriele Ihorst, Claudia Wehr, Reinhard Marks, Heiko Becker, Justus Duyster, Ralph Wäsch, Jürgen Finke, Michael Lübbert
Journal: Blood (2023)
ROS-Driven Structural and Functional Fibrinogen Modifications Are Reverted By JAK Inhibition in Myeloproliferative Neoplasms
Authors: Daniele Tibullo, Giuseppe Alberto Palumbo, Cesarina Giallongo, Anna Longo, Andrea Duminuco, Francesco Di Raimondo, Enrico La Spina, Giovanni Li Volti, Flavia Rita Argento, Eleonora Fini, Serena Borghi, Claudia Fiorillo, Niccolò Taddei, Matteo Becatti
Journal: Blood (2023)
A Drop‐By‐Drop Self‐Assembled All‐Natural Hydrogel as a Desensitizer for Rapid and Enduring Management of Dentin Hypersensitivity
Authors: Wanshan Gao, Yang Liu, Mingjing Li, Mingming Ding, Li Cheng, Chunmei Ding, Jiaojiao Yang, Jianshu Li, Jun Luo, Rongmin Qiu
Journal: Advanced Healthcare Materials (2023)

Dentin hypersensitivity (DH) is a prevalent dental condition arising from the exposure of dentin tubules (DTs), leading to discomfort upon external stimuli. However, achieving swift and profound occlusion of these exposed DTs for immediate and enduring relief remains challenging due to the intricate dentin structure and oral environment. Herein, a pioneering and facile drop-by-drop strategy involving an in situ generated natural supramolecular hydrogel formed by self-assembling silk fibroin (SF) and tannic acid (TA) within the narrow DT space is proposed. When SF and TA aqueous solutions are applied successively to exposed dentin, they penetrate deeply within DTs and coassemble into compact gels, robustly adhering to DT walls. This yields a rapid and compact occlusion effect with an unprecedented depth exceeding 250 µm, maintaining stable occlusion efficacy even under rigorous in vitro and in vivo erosion and friction conditions for no less than 21 days. Furthermore, the biocompatibility and effective occlusion properties are verified through cell studies in simulated oral settings and an in vivo rabbit model. This study, for the first time, demonstrates the translational potential of hydrogel-based desensitizers in treating DH with prompt action, superior occlusion depth and enduring treatment benefits, holding promise as clinical-friendly restorative solutions for delicate-structured biosystems.
Germinal Center B-Cell-like (GCB) Phenotype Predicts Improved Outcomes in Central Nervous System Diffuse Large B-Cell Lymphoma Patients Receiving Stereotactic Radiosurgery (SRS)
Authors: Farhan Azad, Fatemeh Fekrmandi, Mody Amin, Victor Goulenko, Katy Wang, Kris Attwood, Dheerendra Prasad, Francisco J. Hernandez-Ilizaliturri
Journal: Blood (2023)
Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients
Authors: Mostafa Faisal Mohammed Saleh, Ahmed Kotb Abdrabou, Yahya Hummadi, Nader Elatassi, Taimor Hussain, Haroon Alfadhil, Ahmed Bin salman, Momen Nassani, Yazeed Bajuaifer, Mohamed Isam Sharif, Marwa Nassar, Sarah Samarkandi, Heba Madien, Amal Hejab, Ahmed Alnughmush, Ruah Alyamany, Abdullah Alamer, Ayman Saad, Mansour Alfayez, Abdulwahab Albabtain, Ahmad S. Alotaibi, Alfadel Alshaibani, Saud Alhayli, Marwan Shaheen, Ali D Alahmari, Feras Abdulaziz Alfraih, Riad Elfakih, Syed Osman Ahmed, Walid Rasheed, Naeem A. Chaudhri, Fahad Alsharif, Hazza A Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Amr Hanbali
Journal: Blood (2023)
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Elotuzumab, Isatuximab, and Selinexor-Based Regimens in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma with 1-3 Prior Lines of Therapy Using a Matching-Adjusted Indirect Comparison
Authors: Noemi Puig, Joris Diels, Suzy van Sanden, João Mendes, Teresa Hernando, Patricia Cost, Jordan M. Schecter, Nikoletta Lendvai, Nitin Patel, José María Sanchez-Pina, Serena Rocchi
Journal: Blood (2023)
Differences in Molecular Alterations and Clinical Outcomes By Ethnicity for Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax
Authors: Edward Zhou, Stephanie Boisclair, Phyu Thin Naing, Richa Thakur, Bradley Goldberg, Erin Jou, David W Chitty, Jonathan E Kolitz
Journal: Blood (2023)
Efficacy of Bortezomib Combined with Hyper-CVAD in Adults with Relapsed Acute Lymphoblastic Leukemia or Positive Measurable Residual Disease
Authors: Christian Omar Ramos Peñafiel, Daniela Pérez Sámano, Adán Germán Gallardo-Rodríguez, Irma Olarte Carrillo, Camila Terreros Palacios, Carlos Martínez Murillo, Gilberto Israel Barranco Lampón, Álvaro Cabrera García, Humberto Baldemar Castellanos Sinco, Adolfo Martínez Tovar
Journal: Blood (2023)
Azacitidine Combined with Interferon α for Preemptive Treatment of AML/MDS after Allogeneic Peripheral Blood Stem Cell Transplantation：a Prospecitive Phase II Study
Authors: Chongmei Huang, Jun Yang, Yin Tong, Huiying Qiu, Kun Zhou, Xinxin Xia, Ying Zhang, Chang Shen, Liping Wan, Xianmin Song
Journal: Blood (2023)
Test-the-Test: Clinical Utility of Comprehensive Whole Exome Sequencing and RNA-Seq for Patients with Lymphoma
Authors: Dai Chihara, Kumudha Balakrishnan, Gita Masand, Anna Novokreshchenova, Alexander Bagaev, Nikita Kotlov, Ekaterina Postovalova, Eduardo Shugaev-Mendosa, Yuliya Gracheva, Anna Love, Krystle Nomie, Nathan Fowler, Christopher R. Flowers, Jason Westin
Journal: Blood (2023)
Predicting Disease Progression from Idiopathic Cytopenia of Undetermined Significance to Myeloid Malignancies Using a Machine Learning-Based Approach
Authors: Eun-Ji Choi, Jiye Han, Tae Joon Jun, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Kyoo Hyung Lee, Young-Hak Kim, Je-Hwan Lee
Journal: Blood (2023)
Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin Lymphoma: Real-World Data in Chinese Population
Authors: Zixun Yan, Dehui Zou, Yuhua Li, Xiaojian Zhu, Dongmei Ji, Wenbin Qian, Ying Lu, Chunyan Ji, Keshu Zhou, Hongmei Jing, Hua Yang, Lanfang Li, Fei Li, Kailin Xu, Ting Niu, Depei Wu, Yu Hu, Weili Zhao
Journal: Blood (2023)
CRLF2 Expression in Mexicans with Acute Lymphoblastic Leukemia across the Age Spectrum
Authors: Héctor A. Martínez-Espinosa, Nereida Méndez-Ramírez, Julia Colunga Pedraza, Eli Fuentes-Chávez, Rosario Salazar-Riojas, Odra L. Martínez-González, Antonio Vega-Mateos, Oscar Gonzalez Llano, Ingrid López-Reyna, David Gomez-Almaguer, Andres Gomez-De Leon, Vanessa Treviño-Sordia, Roberto Solano-Texta
Journal: Blood (2023)
Germline Determinants of Toxicity and Efficacy in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 Autologous CAR T-Cell Therapy
Authors: Paolo Strati, Amanda Brandt, Jared Henderson, Jason Westin, Loretta J. Nastoupil, Ajlan Al Zaki, Andrew P Jallouk, Sherry Adkins, Elizabeth J. Shpall, Partow Kebriaei, Jeremy Ramdial, Neeraj Y. Saini, Sairah Ahmed, Christopher R. Flowers, Sattva S. Neelapu, Michelle Hildebrandt
Journal: Blood (2023)
Establishing Costs for Commercial Chimeric Antigen Receptor T-Cell (Tisagenlecleucel; Kymriah) in Children and Young Adult B-Cell Acute Lymphoblastic Leukemia; A Merged Analysis from the Prwcc and PHIS
Authors: Prakash Satwani, Karen Chao, Maria Lopez-Garcia, Matt Hall, Zhezhen Jin, Lena E Winestone, Danielle Novetsky Friedman, Rachel Phelan, Christina Baggott, Samuel John, Holly L. Pacenta, Theodore W. Laetsch, Christine L Phillips, Michael R Verneris, Vanessa A. Fabrizio, Amy Keating, Julie-An Talano, Amy Moskop, Susanne H.C. Baumeister, Muna Qayed, Doug Douglas Myers, Erin Marie Hall, Snehit Prabhu, Khanh Nguyen, Casey A Carr, Crystal L. Mackall, John K Lin, Jeremy Goldhaber-Fiebert, Liora Michal Schultz
Journal: Blood (2023)
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study
Authors: Mirko Farina, Maria Chiara Scaini, Filippo Frioni, Edoardo Campodonico, Ginevra Traverso, Gianluca Cavallaro, Attilio Olivieri, Alessandro Leoni, Simone Pellizzeri, Piero Galieni, Simona Bernardi, Giovanni Campisi, Nicola Di Renzo, Vera Radici, Enrico Morello, Nicola Polverelli, Francesca Patriarca, Paola Carluccio, Cristina Skert, Cristina Catoni, Cristina Poggiana, Antonella Facchinetti, Francesca Bonifazi, Edoardo Benedetti, Camillo Almici, Patrizia Chiusolo, Jacopo Peccatori, Michele Malagola, Domenico Russo
Journal: Blood (2023)
Tagraxofusp Maintenance Post-Hematopoietic Stem Cell Transplantation Provides Long-Term Survival and Manageable Safety for a Patient with Blastic Plasmacytoid Dendritic Cell Neoplasm
Authors: Qaiser Bashir, Marina Y. Konopleva, Glorette Abueg, Jeremy Ramdial, Chitra Hosing, Samer A. Srour, Amin Alousi, Uday R. Popat, Yago Nieto, Gheath Alatrash, Richard E. Champlin, Elizabeth J. Shpall, Muzaffar H. Qazilbash, Naveen Pemmaraju
Journal: Blood (2023)
Evaluating the Effectiveness of Risk Adjustment Using Dynamic Frailty Assessment in Treating Newly Diagnosed Multiple Myeloma in Elderly Patients
Authors: Jianmei Xu, Hua Xue, Songying Zhao, Jing Wang, Huimei Guo, Jiangbo Zhang, Jia Liu, Mingjie Tian, Luoming Hua, Mingfeng Zhao
Journal: Blood (2023)
Allogeneic (Allo-SCT) Versus Autologous Stem-Cell Transplantation (Auto-SCT) after Relapse to First Line Auto-SCT in Multiple Myeloma: A Meta-Analysis with Predominantly Individual Patient Data
Authors: Heinz Ludwig, Takashi Ikeda, Cesar O. Freytes, Koji Kawamura, Yoshiko Atsuta, Hiroyuki Takamatsu, David H. Vesole, Hari Parameswaran, Axel Hinke
Journal: Blood (2023)
Aplastic Anemia: Insight from a Single Center Experience
Authors: Parth C. Patel, Najla H Al Ali, Onyee Chan, Seongseok Yun, Andrew T. Kuykendall, Eric Padron, Kendra Sweet, Alison R. Walker, Jeffrey Lancet, David A Sallman, Michael V. Jaglal, Rami S. Komrokji
Journal: Blood (2023)
Predictive Value of <i>BCR::ABL1</i> Transcripts Kinetics in the Molecular Relapse of Chronic Myeloid Leukemia Patients after Tyrosine Kinase Inhibitors Discontinuation: Results from the DES-CML Study
Authors: Bruna A Murbach, Gislaine Borba Oliveira, Leonardo Carvalho Palma, Eliana C M CM Miranda, Guilherme D Amarante, Graziele CP Furlin, Isabella Macedo Toni, Carmino De Souza, Lorena Figueiredo-Pontes, Katia B Pagnano
Journal: Blood (2023)
Abbv-101, a Highly Potent and Selective Clinical Stage Bruton Tyrosine Kinase Degrader for the Treatment of B-Cell Malignancies
Authors: Chin Pan, Tarikere L Gururaja, Haiyan Li, Henry Nguyen, Yongjiao Zhai, Xiaoping Xie, Rong-Xian Ding, Rebecca Mathew, Hana Y Hoh, Zhaozhong J Jia, Bo Liu, Cassandra Shu, Wissam Assaily, Lloyd T Lam, Jacob J Riehm, Claudina Stevenson, Christine Will, Federico Innocenti, Alexey Rivkin
Journal: Blood (2023)
<i>Treatment-Free Remission after Ponatinib Cessation in Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients. the Ponastop Observational Study</i>
Authors: Franck E. Nicolini, Elisabetta Abruzzese, Gabrielle Roth-Guepin, Rami Abi-Tayeh, Vincent Alcazer, Sandrine Hayette, Stéphane Morisset, Françoise Huguet, Miriam Iezza, Fausto Castagnetti, Delphine Rea
Journal: Blood (2023)
Retrospective Analysis of the Impact of Bendamustine Dose Reduction and Chemotherapy on the Outcomes of Follicular Lymphoma
Authors: Yusuke Koba, Kazuhiro Bandai, Naoko Hiranuma, Kensuke Fujiwara, Takahito Kawata, Akira Tamekane, Mitsumasa Watanabe
Journal: Blood (2023)
Reconsidering the Significance of Blast Cut-Offs in Differentiating between MDS and AML Biology
Authors: Helen Shang, Claire Daniel, Michael J. Maranzano, Sarah Stettner, Daria Louise Gaut, Sophie Carlson, Yash Motwani, Alexandra M. Klomhaus, Caspian H. Oliai, Gary J. Schiller, Wanxing Chai-Ho
Journal: Blood (2023)
Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease
Authors: Kaito Harada, Junya Kanda, Masahiro Hirayama, Fumiya Wada, Naoyuki Uchida, Hirohisa Nakamae, Masatsugu Tanaka, Makoto Onizuka, Hiroyuki Ohigashi, Nobuaki Nakano, Takahiro Fukuda, Kazuya Ishiwata, Yumiko Maruyama, Tetsuya Eto, Fumihiko Ishimaru, Yoshiko Atsuta, Hideki Nakasone, Takashi Tanaka
Journal: Blood (2023)
Combinatorial <i>BCL-2</i>/ <i>BCL2L1</i> Expression Predicts Clinical Response to Ruxolitinib in Myelofibrosis
Authors: Giacomo Coltro, Viola Videschi, Francesca Gesullo, Manjola Balliu, Alessandro M. Vannucchi, Paola Guglielmelli
Journal: Blood (2023)
Imaging Practices in Patients with Plasma Cell Dyscrasias across the Asian Myeloma Network - Survey Results and Recommendations
Authors: Natasha Fay Anthony, Wenming Chen, Chim James, Gin Gin Gan, Jeffrey Huang, Kihyun Kim, Teeraya Puavilai, Wee-Joo Chng, Kazuyuki Shimizu, Brian GM Durie, Chandramouli Nagarajan
Journal: Blood (2023)
Curative Potential of Axicabtagene Ciloleucel (Axi-Cel): An Exploratory Long-Term Survival Assessment in Patients with Refractory Large B-Cell Lymphoma from ZUMA-1
Authors: Sattva S. Neelapu, Caron A. Jacobson, Armin Ghobadi, David B. Miklos, Lazaros J. Lekakis, Clare Spooner, Jenny J. Kim, Harry Miao, Allen Xiaodong Xue, Yan Zheng, Frederick L. Locke
Journal: Blood (2023)
A Study on Heterogeneity and Early Response to Chemotherapy in Pediatric ETV6-RUNX1 Positive Acute Lymphoblastic Leukemia By RNA-Seq Expression Profile
Authors: Xueling Zheng, Chunyu Zhou, Ruidong Zhang, Chao Gao, Jingdong Han, Tianyou Wang, Huyong Zheng
Journal: Blood (2023)
Unveiling Novel Therapeutic Targets for CAR Therapy in Multiple Myeloma through Single-Cell RNA Sequencing
Authors: Francesca Garofano, Anna Maria Corsale, Mojtaba Shekarkar Azgomi, Marta Di Simone, Maria Speciale, Cristina Aquilina, Annamaria Gulla, Serena Meraviglia, Nadia Caccamo, Francesco Dieli, Sergio Siragusa, Cirino Botta
Journal: Blood (2023)